Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis

Clinical trial NCT06104618 · RECRUITING

Trial details

NCT number: NCT06104618
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Penile Squamous Cell Carcinoma Stage III Penile Cancer AJCC v8 Stage IV Penile Cancer AJCC v8 Unresectable Penile Squamous Cell Carcinoma

Start date: 2023-12-21
Primary completion: 2028-06-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.